Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Wen Jun Wong"'
Autor:
Tshewang Gyeltshen, Hoon Shien Teh, Ching Ee Loo, Nicholas Yee Liang Hing, Wei Yin Lim, Shridevi Subramaniam, Wen Jun Wong, Zoie Shui-Yee Wong, Wen Yea Hwong
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Cancer represents a significant global public health challenge, with escalating incidence rates straining healthcare systems. Malaysia, like many nations, has witnessed a rise in cancer cases, particularly among the younger popula
Externí odkaz:
https://doaj.org/article/c18eae5e79924389a45a5a04b02f221b
Autor:
Amanda Wei-Yin Lim, Chin Tho Leong, Mohamad Aziz Salowi, Yvonne Mei Fong Lim, Wen Jun Wong, Wen Yea Hwong
Publikováno v:
Public Health in Practice, Vol 7, Iss , Pp 100469- (2024)
Background: Elective surgeries were suspended during the national lockdown in March 2020 to curb the spread of the COVID-19 pandemic in Malaysia. We sought to evaluate the impact of the lockdown on cataract surgeries and suggest lessons for future ou
Externí odkaz:
https://doaj.org/article/bc8dd2b955d24320a34aed9d1a318585
The effects of enhanced primary healthcare interventions on primary care providers’ job satisfaction
Autor:
Wen Jun Wong, Aisyah Mohd Norzi, Swee Hung Ang, Chee Lee Chan, Faeiz Syezri Adzmin Jaafar, Sheamini Sivasampu
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background In response to the rising burden of cardiovascular risk factors, the Malaysian government has implemented Enhanced Primary Healthcare (EnPHC) interventions in July 2017 at public clinic level to improve management and clinical out
Externí odkaz:
https://doaj.org/article/d42f0b1f380d4bb0acb52b5387915621
Autor:
Kennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, Desiree Shu Hui Tay, Ailica Wan Xin Lee, Andrea Jing Shi Ang, Lawrence Wen Jun Wong, Su Pin Choo, David Wai-Meng Tai, Joycelyn Jie Xin Lee
Publikováno v:
Liver Cancer, Pp 1-13 (2021)
Introduction: Development of immune-related adverse events (irAEs) has been associated with enhanced efficacy with the use of immune checkpoint inhibitors (ICIs). It remains unknown whether such an association exists in advanced hepatocellular carcin
Externí odkaz:
https://doaj.org/article/496d27c9aa9f4d5e9ef0778f2382933a
Autor:
Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, Ailica Wan Xin Lee, Desiree Shu Hui Tay, Jack Jie En Tan, Sze Huey Tan, Su Pin Choo, David Wai‐Meng Tai, Joycelyn Jie Xin Lee
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 19:312-319
Combination therapy with immune checkpoint inhibitor (ICI) and antivascular endothelial growth factor (anti-VEGF) is currently the first line treatment for advanced hepatocellular carcinoma (aHCC). However, there are many patients who may not be able
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0791ffd4d9571a3c08be542d6394736d
https://doi.org/10.1111/ajco.13837
https://doi.org/10.1111/ajco.13837
Autor:
Joycelyn Lee, Kennedy Yao Yi Ng, David Wai-Meng Tai, Andrea Jing Shi Ang, Lawrence Wen Jun Wong, Sze Huey Tan, Su Pin Choo
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 17
Introduction Immune checkpoint inhibitor (ICI) use in advanced hepatocellular carcinoma (HCC) is increasing. Real-world data on efficacy and safety, however, are lacking. Methods We conducted a retrospective review of all patients with advanced HCC s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c812390d856dbe1e4ab7cb636240e9b
https://doi.org/10.1111/ajco.13454
https://doi.org/10.1111/ajco.13454
Autor:
Swee Hung Ang, Sunita Shanmugam, Sarah Hui Li Pang, Yvonne Mei Fong Lim, Rifat Atun, Faeiz Syezri Adzmin Jaafar, Dennis Ross-Degnan, Noraziani Khamis, Xin Rou Teh, Sheamini Sivasampu, Siti Aminah Ismail, Masliyana Husin, Nazrila Hairizan Nasir, Dian Kusuma, Mohd Safiee Ismail, Wen Jun Wong, Su Miin Ong
Publikováno v:
Primary Health Care Research & Development
Aim: This paper describes the study protocol, which aims to evaluate the effectiveness of a multifaceted intervention package called ‘Enhanced Primary Healthcare’ (EnPHC) on the process of care and intermediate clinical outcomes among patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34256204af1dabbb64996a3f79cdba21
http://hdl.handle.net/10044/1/82330
http://hdl.handle.net/10044/1/82330
Publikováno v:
Singapore Medical Journal. 59:230-239
Traditional Chinese medicine (TCM)-based herbal therapies have gained increasing popularity worldwide, raising concerns of its efficacy, safety profile and potential interactions with Western medications. Antithrombotic agents are among the most comm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b87ca37d13fbfaca195ab08e7e18a7ef
https://doi.org/10.11622/smedj.2018051
https://doi.org/10.11622/smedj.2018051
Autor:
Sze Huey Tan, Su Pin Choo, Joycelyn Lee, Andrea Jing Shi Ang, David Wai-Meng Tai, Lawrence Wen Jun Wong, K. Ng
Publikováno v:
Annals of Oncology. 30:xi23
Background Tyrosine kinase inhibitors (TKI) are the first-line systemic treatment for patients with advanced hepatocellular carcinoma (HCC), while immune checkpoint inhibitors (ICI) were approved for use in the second-line setting in 2018. Results of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2b7c02b731fda13e8ddea0cd51a336f
https://doi.org/10.1093/annonc/mdz449.018
https://doi.org/10.1093/annonc/mdz449.018